Literature DB >> 25363704

Rare variant APOC3 R19X is associated with cardio-protective profiles in a diverse population-based survey as part of the Epidemiologic Architecture for Genes Linked to Environment Study.

Dana C Crawford1, Logan Dumitrescu2, Robert Goodloe2, Kristin Brown-Gentry2, Jonathan Boston2, Bob McClellan2, Cara Sutcliffe2, Rachel Wiseman2, Paxton Baker2, Margaret A Pericak-Vance2, William K Scott2, Melissa Allen2, Ping Mayo2, Nathalie Schnetz-Boutaud2, Holli H Dilks2, Jonathan L Haines2, Toni I Pollin2.   

Abstract

BACKGROUND: A founder mutation was recently discovered and described as conferring favorable lipid profiles and reduced subclinical atherosclerotic disease in a Pennsylvania Amish population. Preliminary data have suggested that this null mutation APOC3 R19X (rs76353203) is rare in the general population. METHODS AND
RESULTS: To better describe the frequency and lipid profile in the general population, we as part of the Population Architecture using Genomics and Epidemiology I Study and the Epidemiological Architecture for Genes Linked to Environment Study genotyped rs76353203 in 1113 Amish participants from Ohio and Indiana and 19 613 participants from the National Health and Nutrition Examination Surveys (NHANES III, 1999 to 2002, and 2007 to 2008). We found no carriers among the Ohio and Indiana Amish. Of the 19 613 NHANES participants, we identified 31 participants carrying the 19X allele, for an overall allele frequency of 0.08%. Among fasting adults, the 19X allele was associated with lower triglycerides (n=7603; β=-71.20; P=0.007) and higher high-density lipoprotein cholesterol (n=8891; β=15.65; P=0.0002) and, although not significant, lower low-density lipoprotein cholesterol (n=6502; β= -4.85; P=0.68) after adjustment for age, sex, and race/ethnicity. On average, 19X allele participants had approximately half the triglyceride levels (geometric means, 51.3 to 69.7 versus 134.6 to 141.3 mg/dL), >20% higher high-density lipoprotein cholesterol levels (geometric means, 56.8 to 74.4 versus 50.38 to 53.36 mg/dL), and lower low-density lipoprotein cholesterol levels (geometric means, 104.5 to 128.6 versus 116.1 to 125.7 mg/dL) compared with noncarrier participants.
CONCLUSIONS: These data demonstrate that APOC3 19X exists in the general US population in multiple racial/ethnic groups and is associated with cardio-protective lipid profiles.
© 2014 American Heart Association, Inc.

Entities:  

Keywords:  genetic association studies; genetics; high-density lipoprotein cholesterol; molecular epidemiology; triglycerides

Mesh:

Substances:

Year:  2014        PMID: 25363704      PMCID: PMC4305446          DOI: 10.1161/CIRCGENETICS.113.000369

Source DB:  PubMed          Journal:  Circ Cardiovasc Genet        ISSN: 1942-3268


  28 in total

1.  The effects of scale: variation in the APOA1/C3/A4/A5 gene cluster.

Authors:  Stephanie M Fullerton; Anne V Buchanan; Vibhor A Sonpar; Scott L Taylor; Joshua D Smith; Christopher S Carlson; Veikko Salomaa; Jari H Stengård; Eric Boerwinkle; Andrew G Clark; Deborah A Nickerson; Kenneth M Weiss
Journal:  Hum Genet       Date:  2004-04-24       Impact factor: 4.132

2.  A spectrum of PCSK9 alleles contributes to plasma levels of low-density lipoprotein cholesterol.

Authors:  Ingrid K Kotowski; Alexander Pertsemlidis; Amy Luke; Richard S Cooper; Gloria L Vega; Jonathan C Cohen; Helen H Hobbs
Journal:  Am J Hum Genet       Date:  2006-01-20       Impact factor: 11.025

3.  Evolution and functional impact of rare coding variation from deep sequencing of human exomes.

Authors:  Jacob A Tennessen; Abigail W Bigham; Timothy D O'Connor; Wenqing Fu; Eimear E Kenny; Simon Gravel; Sean McGee; Ron Do; Xiaoming Liu; Goo Jun; Hyun Min Kang; Daniel Jordan; Suzanne M Leal; Stacey Gabriel; Mark J Rieder; Goncalo Abecasis; David Altshuler; Deborah A Nickerson; Eric Boerwinkle; Shamil Sunyaev; Carlos D Bustamante; Michael J Bamshad; Joshua M Akey
Journal:  Science       Date:  2012-05-17       Impact factor: 47.728

4.  Population-based resequencing of ANGPTL4 uncovers variations that reduce triglycerides and increase HDL.

Authors:  Stefano Romeo; Len A Pennacchio; Yunxin Fu; Eric Boerwinkle; Anne Tybjaerg-Hansen; Helen H Hobbs; Jonathan C Cohen
Journal:  Nat Genet       Date:  2007-02-25       Impact factor: 38.330

5.  Maternal lineages and Alzheimer disease risk in the Old Order Amish.

Authors:  Joelle M van der Walt; William K Scott; Susan Slifer; P C Gaskell; Eden R Martin; Kathleen Welsh-Bohmer; Marilyn Creason; Amy Crunk; Denise Fuzzell; Lynne McFarland; Charles C Kroner; C E Jackson; Jonathan L Haines; Margaret A Pericak-Vance
Journal:  Hum Genet       Date:  2005-10-28       Impact factor: 4.132

6.  Identification by whole-genome resequencing of gene defect responsible for severe hypercholesterolemia.

Authors:  Jonathan Rios; Evan Stein; Jay Shendure; Helen H Hobbs; Jonathan C Cohen
Journal:  Hum Mol Genet       Date:  2010-08-18       Impact factor: 6.150

7.  The Next PAGE in understanding complex traits: design for the analysis of Population Architecture Using Genetics and Epidemiology (PAGE) Study.

Authors:  Tara C Matise; Jose Luis Ambite; Steven Buyske; Christopher S Carlson; Shelley A Cole; Dana C Crawford; Christopher A Haiman; Gerardo Heiss; Charles Kooperberg; Loic Le Marchand; Teri A Manolio; Kari E North; Ulrike Peters; Marylyn D Ritchie; Lucia A Hindorff; Jonathan L Haines
Journal:  Am J Epidemiol       Date:  2011-08-11       Impact factor: 4.897

8.  Analysis of 6,515 exomes reveals the recent origin of most human protein-coding variants.

Authors:  Wenqing Fu; Timothy D O'Connor; Goo Jun; Hyun Min Kang; Goncalo Abecasis; Suzanne M Leal; Stacey Gabriel; Mark J Rieder; David Altshuler; Jay Shendure; Deborah A Nickerson; Michael J Bamshad; Joshua M Akey
Journal:  Nature       Date:  2012-11-28       Impact factor: 49.962

9.  A rare functional cardioprotective APOC3 variant has risen in frequency in distinct population isolates.

Authors:  Ioanna Tachmazidou; George Dedoussis; Lorraine Southam; Aliki-Eleni Farmaki; Graham R S Ritchie; Dionysia K Xifara; Angela Matchan; Konstantinos Hatzikotoulas; Nigel W Rayner; Yuan Chen; Toni I Pollin; Jeffrey R O'Connell; Laura M Yerges-Armstrong; Chrysoula Kiagiadaki; Kalliope Panoutsopoulou; Jeremy Schwartzentruber; Loukas Moutsianas; Emmanouil Tsafantakis; Chris Tyler-Smith; Gil McVean; Yali Xue; Eleftheria Zeggini
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

10.  Discovery and refinement of loci associated with lipid levels.

Authors:  Cristen J Willer; Ellen M Schmidt; Sebanti Sengupta; Michael Boehnke; Panos Deloukas; Sekar Kathiresan; Karen L Mohlke; Erik Ingelsson; Gonçalo R Abecasis; Gina M Peloso; Stefan Gustafsson; Stavroula Kanoni; Andrea Ganna; Jin Chen; Martin L Buchkovich; Samia Mora; Jacques S Beckmann; Jennifer L Bragg-Gresham; Hsing-Yi Chang; Ayşe Demirkan; Heleen M Den Hertog; Ron Do; Louise A Donnelly; Georg B Ehret; Tõnu Esko; Mary F Feitosa; Teresa Ferreira; Krista Fischer; Pierre Fontanillas; Ross M Fraser; Daniel F Freitag; Deepti Gurdasani; Kauko Heikkilä; Elina Hyppönen; Aaron Isaacs; Anne U Jackson; Åsa Johansson; Toby Johnson; Marika Kaakinen; Johannes Kettunen; Marcus E Kleber; Xiaohui Li; Jian'an Luan; Leo-Pekka Lyytikäinen; Patrik K E Magnusson; Massimo Mangino; Evelin Mihailov; May E Montasser; Martina Müller-Nurasyid; Ilja M Nolte; Jeffrey R O'Connell; Cameron D Palmer; Markus Perola; Ann-Kristin Petersen; Serena Sanna; Richa Saxena; Susan K Service; Sonia Shah; Dmitry Shungin; Carlo Sidore; Ci Song; Rona J Strawbridge; Ida Surakka; Toshiko Tanaka; Tanya M Teslovich; Gudmar Thorleifsson; Evita G Van den Herik; Benjamin F Voight; Kelly A Volcik; Lindsay L Waite; Andrew Wong; Ying Wu; Weihua Zhang; Devin Absher; Gershim Asiki; Inês Barroso; Latonya F Been; Jennifer L Bolton; Lori L Bonnycastle; Paolo Brambilla; Mary S Burnett; Giancarlo Cesana; Maria Dimitriou; Alex S F Doney; Angela Döring; Paul Elliott; Stephen E Epstein; Gudmundur Ingi Eyjolfsson; Bruna Gigante; Mark O Goodarzi; Harald Grallert; Martha L Gravito; Christopher J Groves; Göran Hallmans; Anna-Liisa Hartikainen; Caroline Hayward; Dena Hernandez; Andrew A Hicks; Hilma Holm; Yi-Jen Hung; Thomas Illig; Michelle R Jones; Pontiano Kaleebu; John J P Kastelein; Kay-Tee Khaw; Eric Kim; Norman Klopp; Pirjo Komulainen; Meena Kumari; Claudia Langenberg; Terho Lehtimäki; Shih-Yi Lin; Jaana Lindström; Ruth J F Loos; François Mach; Wendy L McArdle; Christa Meisinger; Braxton D Mitchell; Gabrielle Müller; Ramaiah Nagaraja; Narisu Narisu; Tuomo V M Nieminen; Rebecca N Nsubuga; Isleifur Olafsson; Ken K Ong; Aarno Palotie; Theodore Papamarkou; Cristina Pomilla; Anneli Pouta; Daniel J Rader; Muredach P Reilly; Paul M Ridker; Fernando Rivadeneira; Igor Rudan; Aimo Ruokonen; Nilesh Samani; Hubert Scharnagl; Janet Seeley; Kaisa Silander; Alena Stančáková; Kathleen Stirrups; Amy J Swift; Laurence Tiret; Andre G Uitterlinden; L Joost van Pelt; Sailaja Vedantam; Nicholas Wainwright; Cisca Wijmenga; Sarah H Wild; Gonneke Willemsen; Tom Wilsgaard; James F Wilson; Elizabeth H Young; Jing Hua Zhao; Linda S Adair; Dominique Arveiler; Themistocles L Assimes; Stefania Bandinelli; Franklyn Bennett; Murielle Bochud; Bernhard O Boehm; Dorret I Boomsma; Ingrid B Borecki; Stefan R Bornstein; Pascal Bovet; Michel Burnier; Harry Campbell; Aravinda Chakravarti; John C Chambers; Yii-Der Ida Chen; Francis S Collins; Richard S Cooper; John Danesh; George Dedoussis; Ulf de Faire; Alan B Feranil; Jean Ferrières; Luigi Ferrucci; Nelson B Freimer; Christian Gieger; Leif C Groop; Vilmundur Gudnason; Ulf Gyllensten; Anders Hamsten; Tamara B Harris; Aroon Hingorani; Joel N Hirschhorn; Albert Hofman; G Kees Hovingh; Chao Agnes Hsiung; Steve E Humphries; Steven C Hunt; Kristian Hveem; Carlos Iribarren; Marjo-Riitta Järvelin; Antti Jula; Mika Kähönen; Jaakko Kaprio; Antero Kesäniemi; Mika Kivimaki; Jaspal S Kooner; Peter J Koudstaal; Ronald M Krauss; Diana Kuh; Johanna Kuusisto; Kirsten O Kyvik; Markku Laakso; Timo A Lakka; Lars Lind; Cecilia M Lindgren; Nicholas G Martin; Winfried März; Mark I McCarthy; Colin A McKenzie; Pierre Meneton; Andres Metspalu; Leena Moilanen; Andrew D Morris; Patricia B Munroe; Inger Njølstad; Nancy L Pedersen; Chris Power; Peter P Pramstaller; Jackie F Price; Bruce M Psaty; Thomas Quertermous; Rainer Rauramaa; Danish Saleheen; Veikko Salomaa; Dharambir K Sanghera; Jouko Saramies; Peter E H Schwarz; Wayne H-H Sheu; Alan R Shuldiner; Agneta Siegbahn; Tim D Spector; Kari Stefansson; David P Strachan; Bamidele O Tayo; Elena Tremoli; Jaakko Tuomilehto; Matti Uusitupa; Cornelia M van Duijn; Peter Vollenweider; Lars Wallentin; Nicholas J Wareham; John B Whitfield; Bruce H R Wolffenbuttel; Jose M Ordovas; Eric Boerwinkle; Colin N A Palmer; Unnur Thorsteinsdottir; Daniel I Chasman; Jerome I Rotter; Paul W Franks; Samuli Ripatti; L Adrienne Cupples; Manjinder S Sandhu; Stephen S Rich
Journal:  Nat Genet       Date:  2013-10-06       Impact factor: 38.330

View more
  12 in total

1.  Using primary murine intestinal enteroids to study dietary TAG absorption, lipoprotein synthesis, and the role of apoC-III in the intestine.

Authors:  Javeed Jattan; Cayla Rodia; Diana Li; Adama Diakhate; Hongli Dong; Amy Bataille; Noah F Shroyer; Alison B Kohan
Journal:  J Lipid Res       Date:  2017-02-03       Impact factor: 5.922

Review 2.  Apolipoprotein C-III: a potent modulator of hypertriglyceridemia and cardiovascular disease.

Authors:  Alison B Kohan
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2015-04       Impact factor: 3.243

3.  Genetically Engineered Hamster Models of Dyslipidemia and Atherosclerosis.

Authors:  Xunde Xian; Yuhui Wang; George Liu
Journal:  Methods Mol Biol       Date:  2022

Review 4.  ANGPTL3 and Apolipoprotein C-III as Novel Lipid-Lowering Targets.

Authors:  Ioannis Akoumianakis; Evangelia Zvintzou; Kyriakos Kypreos; Theodosios D Filippatos
Journal:  Curr Atheroscler Rep       Date:  2021-03-10       Impact factor: 5.113

5.  Role of Rare and Low-Frequency Variants in Gene-Alcohol Interactions on Plasma Lipid Levels.

Authors:  Zhe Wang; Han Chen; Traci M Bartz; Lawrence F Bielak; Daniel I Chasman; Mary F Feitosa; Nora Franceschini; Xiuqing Guo; Elise Lim; Raymond Noordam; Melissa A Richard; Heming Wang; Brian Cade; L Adrienne Cupples; Paul S de Vries; Franco Giulanini; Jiwon Lee; Rozenn N Lemaitre; Lisa W Martin; Alex P Reiner; Stephen S Rich; Pamela J Schreiner; Stephen Sidney; Colleen M Sitlani; Jennifer A Smith; Ko Willems van Dijk; Jie Yao; Wei Zhao; Myriam Fornage; Sharon L R Kardia; Charles Kooperberg; Ching-Ti Liu; Dennis O Mook-Kanamori; Michael A Province; Bruce M Psaty; Susan Redline; Paul M Ridker; Jerome I Rotter; Eric Boerwinkle; Alanna C Morrison
Journal:  Circ Genom Precis Med       Date:  2020-06-08

6.  Population Stratification in the Context of Diverse Epidemiologic Surveys Sans Genome-Wide Data.

Authors:  Matthew T Oetjens; Kristin Brown-Gentry; Robert Goodloe; Holli H Dilks; Dana C Crawford
Journal:  Front Genet       Date:  2016-05-06       Impact factor: 4.599

Review 7.  Triglyceride-Rich Lipoproteins and Remnants: Targets for Therapy?

Authors:  Geesje M Dallinga-Thie; Jeffrey Kroon; Jan Borén; M John Chapman
Journal:  Curr Cardiol Rep       Date:  2016-07       Impact factor: 2.931

8.  Cryptic relatedness in epidemiologic collections accessed for genetic association studies: experiences from the Epidemiologic Architecture for Genes Linked to Environment (EAGLE) study and the National Health and Nutrition Examination Surveys (NHANES).

Authors:  Jennifer Malinowski; Robert Goodloe; Kristin Brown-Gentry; Dana C Crawford
Journal:  Front Genet       Date:  2015-10-26       Impact factor: 4.599

Review 9.  The Roles of ApoC-III on the Metabolism of Triglyceride-Rich Lipoproteins in Humans.

Authors:  Jan Borén; Chris J Packard; Marja-Riitta Taskinen
Journal:  Front Endocrinol (Lausanne)       Date:  2020-07-28       Impact factor: 5.555

10.  Frequency and phenotype consequence of APOC3 rare variants in patients with very low triglyceride levels.

Authors:  Dana C Crawford; Nicole A Restrepo; Kirsten E Diggins; Eric Farber-Eger; Quinn S Wells
Journal:  BMC Med Genomics       Date:  2018-09-14       Impact factor: 3.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.